Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12621]

ASH 2015: Combination therapy with idelalisib better prevents disease progression in relapsed or treatment-resistant chronic lymphocytic leukaemia than current regimen

ASH 2015: Combination therapy with idelalisib better prevents disease progression in relapsed or treatment...

ASH 2015: Research provides guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

ASH 2015: Research provides guidance for anticoagulation management in the setting of thrombocytopenia in cancer...

ASH 2015: Genetic variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified

ASH 2015: Genetic variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified

ASH 2015: Genetic variant signifies higher risk for avascular necrosis in children with acute leukaemia

ASH 2015: Genetic variant signifies higher risk for avascular necrosis in children with acute leukaemia

ASH 2015: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high risk clinical features but outstanding outcomes

ASH 2015: Classification system based on cytogenetics and treatment response identifies leukaemia patients with...

$ASH 2015: Carfilzomib superior to bortezomib in relapsed and refractory multiple myeloma$

ASH 2015: Carfilzomib superior to bortezomib in relapsed and refractory multiple myeloma

ASH 2015: Engineered cells to target multiple myeloma shows early promise

ASH 2015: Engineered cells to target multiple myeloma shows early promise

ASH 2015: Engineered donor T cells may eradicate progressive disease after stem cell transplant

ASH 2015: Engineered donor T cells may eradicate progressive disease after stem cell transplant

Researchers isolate cells implicated with breast cancer-derived brain tumors

Researchers isolate cells implicated with breast cancer-derived brain tumors

Depressed head and neck cancer patients three-and-one-half times less likely to survive, have higher recurrence risk

Depressed head and neck cancer patients three-and-one-half times less likely to survive, have higher recurrence...

More from ecancer